IndraLab

Statements


| 2

reach
"It should be noted, however, that myricetin did not inhibit hERG1 channels, and luteolin was not examined XREF_BIBR."

reach
"Furthermore, Myricetin’s non-inhibition of hERG I and II highlights its potential for enhanced cardiac safety, an important consideration during drug development."